Surgery Partners/$SGRY
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Surgery Partners
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
- Ticker
- $SGRY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 16,000
- Headquarters
- Brentwood, United States
- Website
- www.surgerypartners.com
Surgery Partners Metrics
BasicAdvanced
$3B
-
-$0.69
1.92
-
Price and volume
Market cap
$3B
Beta
1.92
52-week high
$23.37
52-week low
$11.41
Average daily volume
4.4M
Financial strength
Current ratio
1.946
Quick ratio
1.44
Long term debt to equity
1.131
Total debt to equity
1.173
Interest coverage (TTM)
1.60%
Profitability
EBITDA (TTM)
646.4
Gross margin (TTM)
22.51%
Net profit margin (TTM)
-2.63%
Operating margin (TTM)
13.94%
Effective tax rate (TTM)
20.02%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
3.66%
Return on equity (TTM)
2.32%
Valuation
Price to revenue (TTM)
0.883
Price to book
1.8
Price to tangible book (TTM)
-0.84
Price to free cash flow (TTM)
15.85
Free cash flow yield (TTM)
6.31%
Free cash flow per share (TTM)
1.464
Growth
Revenue change (TTM)
3.99%
Earnings per share change (TTM)
-51.56%
3-year revenue growth (CAGR)
8.15%
10-year revenue growth (CAGR)
12.48%
3-year earnings per share growth (CAGR)
11.79%
10-year earnings per share growth (CAGR)
14.11%
What the Analysts think about Surgery Partners
Analyst ratings (Buy, Hold, Sell) for Surgery Partners stock.
Analyst projections of the future price of Surgery Partners stock.
Bulls say / Bears say
HealthSpan Partners has agreed to acquire Surgery Partners for $23.50 a share in cash, giving shareholders a defined value if the deal closes. Bain Capital affiliates will roll their shares into the buyer and remain a significant partner. (Business Wire)
Core facility revenue rose 5.0% in the second quarter, supported by higher revenue per case, while 191 new physicians began using the company’s facilities. That recruiting pipeline could support further organic growth. (Surgery Partners Inc., The Motley Fool)
The completed Idaho Falls sale brought in $587 million in net cash proceeds, which Surgery Partners says will be used mainly to pay down debt. The disposal also sharpens the business around short-stay surgery and is expected to reduce Medicaid exposure to below 2% of revenue. (Surgery Partners Inc.)
The proposed buyout is not yet certain: it requires shareholder and regulatory approvals and is expected to close only in the first quarter of 2027. A delay or failure would leave investors exposed to the standalone business instead. (Business Wire)
Second-quarter same-facility case growth was just 0.3%, while adjusted EBITDA fell 2.9% and the net loss widened to $15 million. Revenue growth therefore has yet to translate into stronger earnings. (Surgery Partners Inc.)
The balance sheet remains stretched: net-debt leverage was 4.4 times at June-end, while first-half interest expense increased and operating cash flow fell year on year. This combination could limit financial flexibility even after the Idaho Falls debt paydown. (U.S. Securities and Exchange Commission)
Data summarised monthly by Lightyear AI. Last updated on 26 Oct 2026.
Surgery Partners Financial Performance
Revenues and expenses
Surgery Partners Earnings Performance
Company profitability
Upcoming events
No upcoming events
Surgery Partners News
AllArticlesVideos
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger
Newsfile Corp2 days ago
Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY
Business Wire3 days ago
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
Business Wire4 days ago
Funds containing Surgery Partners
AllUSDEURGBP
Fund name | Fund size | $SGRY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.06% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.06% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.05% |
iShares MSCI World Small Cap£WLDS | $9B | 0.02% |
iShares MSCI World Small Cap$WSML | $9B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.